Integrated Molecular Characterization of Uterine Carcinosarcoma
Andrew D Cherniack,Hui Shen,Vonn Walter,Chip Stewart,Bradley A Murray,Reanne Bowlby,Xin Hu,Shiyun Ling,Robert A Soslow,Russell R Broaddus,Rosemary E Zuna,Gordon Robertson,Peter W Laird,Raju Kucherlapati,Gordon B Mills,Cancer Genome Atlas Research Network,John N Weinstein,Jiashan Zhang,Rehan Akbani,Douglas A Levine,Adrian Ally,J Todd Auman,Miruna Balasundaram,Saianand Balu,Stephen B Baylin,Rameen Beroukhim,Tom Bodenheimer,Faina Bogomolniy,Lori Boice,Moiz S Bootwalla,Jay Bowen,Russell Broaddus,Denise Brooks,Rebecca Carlsen,Juok Cho,Eric Chuah,Sudha Chudamani,Kristian Cibulskis,Melissa Cline,Fanny Dao,Mutch David,John A Demchok,Noreen Dhalla,Sean Dowdy,Ina Felau,Martin L Ferguson,Scott Frazer,Jessica Frick,Stacey Gabriel,Julie M Gastier-Foster,Nils Gehlenborg,Mark Gerken,Gad Getz,Manaswi Gupta,David Haussler,D Neil Hayes,David I Heiman,Julian Hess,Katherine A Hoadley,Robert Hoffmann,Robert A Holt,Alan P Hoyle,Mei Huang,Carolyn M Hutter,Stuart R Jefferys,Steven J M Jones,Corbin D Jones,Rupa S Kanchi,Cyriac Kandoth,Katayoon Kasaian,Sarah Kerr,Jaegil Kim,Phillip H Lai,Eric Lander,Michael S Lawrence,Darlene Lee,Kristen M Leraas,Ignaty Leshchiner,Tara M Lichtenberg,Pei Lin,Jia Liu,Wenbin Liu,Yuexin Liu,Laxmi Lolla,Yiling Lu,Yussanne Ma,Dennis T Maglinte,Marco A Marra,Michael Mayo,Shaowu Meng,Matthew Meyerson,Piotr A Mieczkowski,Richard A Moore,Lisle E Mose,Andrew J Mungall,Karen Mungall,Rashi Naresh,Michael S Noble,Narciso Olvera,Joel S Parker,Charles M Perou,Amy H Perou,Todd Pihl,Amie J Radenbaugh,Nilsa C Ramirez,W Kimryn Rathmell,Jeffrey Roach,A Gordon Robertson,Sara Sadeghi,Gordon Saksena,Helga B Salvesen,Jacqueline E Schein,Steven E Schumacher,Margi Sheth,Yan Shi,Juliann Shih,Janae V Simons,Payal Sipahimalani,Tara Skelly,Heidi J Sofia,Matthew G Soloway,Carrie Sougnez,Charlie Sun,Angela Tam,Donghui Tan,Roy Tarnuzzer,Nina Thiessen,Leigh B Thorne,Kane Tse,Jill Tseng,David J Van Den Berg,Umadevi Veluvolu,Roel G W Verhaak,Doug Voet,Amanda von Bismarck,Yunhu Wan,Zhining Wang,Chen Wang,Daniel J Weisenberger,Matthew D Wilkerson,Boris Winterhoff,Lisa Wise,Tina Wong,Ye Wu,Liming Yang,Jean C Zenklusen,Jiashan Julia Zhang,Hailei Zhang,Wei Zhang,Jing-Chun Zhu,Erik Zmuda
DOI: https://doi.org/10.1016/j.ccell.2017.02.010
IF: 50.3
2017-03-13
Cancer Cell
Abstract:We performed genomic, epigenomic, transcriptomic, and proteomic characterizations of uterine carcinosarcomas (UCSs). Cohort samples had extensive copy-number alterations and highly recurrent somatic mutations. Frequent mutations were found in TP53, PTEN, PIK3CA, PPP2R1A, FBXW7, and KRAS, similar to endometrioid and serous uterine carcinomas. Transcriptome sequencing identified a strong epithelial-to-mesenchymal transition (EMT) gene signature in a subset of cases that was attributable to epigenetic alterations at microRNA promoters. The range of EMT scores in UCS was the largest among all tumor types studied via The Cancer Genome Atlas. UCSs shared proteomic features with gynecologic carcinomas and sarcomas with intermediate EMT features. Multiple somatic mutations and copy-number alterations in genes that are therapeutic targets were identified.